Contraceptive Agents, Female
"Contraceptive Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
| Descriptor ID |
D003271
|
| MeSH Number(s) |
D27.505.696.875.360.276 D27.505.954.705.360.276
|
| Concept/Terms |
Contraceptive Agents, Female- Contraceptive Agents, Female
- Agents, Female Contraceptive
- Female Contraceptive Agents
- Contraceptives, Female
- Female Contraceptives
|
Below are MeSH descriptors whose meaning is more general than "Contraceptive Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Contraceptive Agents, Female".
This graph shows the total number of publications written about "Contraceptive Agents, Female" by people in this website by year, and whether "Contraceptive Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 2 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 2 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Contraceptive Agents, Female" by people in Profiles.
-
Characteristics of parents who think intrauterine devices or contraceptive implants are "best" for their daughter: An exploratory analysis in Dallas, Texas. Contraception. 2023 09; 125:110084.
-
Are Illinois Contraceptive Providers Comfortable Providing Care to Adolescents? Results From a Statewide Provider Needs Assessment. Womens Health Issues. 2023 Jan-Feb; 33(1):36-44.
-
Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years. Contraception. 2021 06; 103(6):444-449.
-
Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 11; 132(5):1252-1264.
-
Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes. Fertil Steril. 2018 07 01; 110(1):83-88.
-
Patient-centered Contraceptive Counseling and Prescribing. Clin Obstet Gynecol. 2018 03; 61(1):27-39.
-
Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women. Contraception. 2018 04; 97(4):357-362.
-
Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen. Obstet Gynecol. 2017 05; 129(5):800-809.
-
A Qualitative Application of Diffusion of Innovations to Adolescents' Perceptions of Long-Acting Reversible Contraception's Attributes. J Pediatr Adolesc Gynecol. 2017 Aug; 30(4):484-490.
-
Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study. Contraception. 2017 Mar; 95(3):245-250.